Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ANPEP | P15144 | 4/20 | 0.52 |
| ▸ | RNPEP | Q9H4A4 | 3/20 | 0.52 |
| ▸ | DNPEP | Q9ULA0 | 3/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.49 |
| ▸ | RAB9A | P51151 | 3/20 | 0.49 |
| ▸ | GAA | P10253 | 1/20 | 0.49 |
| ▸ | NPC1 | O15118 | 2/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | PKM | P14618 | 1/20 | 0.40 |
| ▸ | TGFBR1 | P36897 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.36 |
| ▸ | MMP2 | P08253 | 1/20 | 0.36 |
| ▸ | MMP8 | P22894 | 1/20 | 0.36 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.35 |
| ▸ | CNR1 | P21554 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25557372 | 0.88 | ANPEP (0.41) | ANPEPRNPEPDNPEPSMN1; SMN2RAB9A | |
| SCHEMBL157717 | 0.85 | ALDH1A1 (0.45) | ANPEPRNPEPDNPEPSMN1; SMN2RAB9A | |
| SCHEMBL440135 | 0.84 | KDM4E (0.43) | ANPEPRNPEPDNPEPSMN1; SMN2RAB9A | |
| SCHEMBL20503583 | 0.84 | KDM4E (0.43) | ANPEPRNPEPDNPEPSMN1; SMN2RAB9A | |
| SCHEMBL3993428 | 0.84 | KDM4E (0.43) | ANPEPRNPEPDNPEPSMN1; SMN2RAB9A | |
| SCHEMBL20503552 | 0.84 | KDM4E (0.43) | ANPEPRNPEPDNPEPSMN1; SMN2RAB9A | |
| SCHEMBL20503602 | 0.84 | KDM4E (0.43) | ANPEPRNPEPDNPEPSMN1; SMN2RAB9A | |
| SCHEMBL20503562 | 0.84 | KDM4E (0.43) | ANPEPRNPEPDNPEPSMN1; SMN2RAB9A | |
| SCHEMBL20503614 | 0.84 | KDM4E (0.43) | ANPEPRNPEPDNPEPSMN1; SMN2RAB9A | |
| SCHEMBL20503740 | 0.84 | KDM4E (0.43) | ANPEPRNPEPDNPEPSMN1; SMN2RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 55 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-108329421-B | Emulsifier for emulsifying alkenyl succinic anhydride | 江苏富淼科技股份有限公司 | 2020-04-03 | — | — | CN | claimed |
| US-20180333345-A1 | NON-AQUEOUS COMPOSITIONS OF POLYMERS DERIVED FROM MONOMERS HAVING ACRYLOYL MOIETY AND LACTAM MOIETY AND APPLICATIONS THEREOF | ISP INVESTMENTS LLC (US) | 2018-11-22 | — | — | US | claimed |
| EP-2641927-B1 | Thermosensitive copolymers, and forward osmosis water treatment devices and methods of using the same | SAMSUNG ELECTRONICS CO LTD (KR) | 2018-10-17 | — | — | EP | claimed |
| EP-3377547-A1 | ON-AQUEOUS COMPOSITIONS OF POLYMERS DERIVED FROM MONOMERS HAVING ACRYLOYL MOIETY AND LACTAM MOIETY AND APPLICATIONS THEREOF | ISP Investments LLC (US) | 2018-09-26 | — | — | EP | claimed |
| CN-108329421-A | A kind of emulsifier for alkenyl succinic anhydride emulsification | 江苏富淼科技股份有限公司 | 2018-07-27 | — | — | CN | claimed |
| US-9447239-B2 | Thermosensitive copolymers, forward osmosis water treatment devices including the same, and methods of producing and using the same | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2016-09-20 | — | — | US | claimed |
| EP-2641927-A1 | Thermosensitive copolymers, and forward osmosis water treatment devices and methods of using the same | Samsung Electronics Co., Ltd (KR) | 2013-09-25 | — | — | EP | claimed |
| US-20130240444-A1 | THERMOSENSITIVE COPOLYMERS, FORWARD OSMOSIS WATER TREATMENT DEVICES INCLUDING THE SAME, AND METHODS OF PRODUCING AND USING THE SAME | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2013-09-19 | — | — | US | claimed |
| US-20230381326-A1 | DRUG DELIVERY SYSTEM FOR TREATING DISEASE | SDG, LLC | 2023-11-30 | — | — | US | disclosed |
| US-11780940-B2 | Hydrate inhibitors | BAKER HUGHES OILFIELD OPERATIONS LLC (US) | 2023-10-10 | — | — | US | disclosed |
| US-20230024332-A1 | Antifouling Polymeric Coating Compositions | THE UNIVERSITY OF BRITISH COLUMBIA (CA) | 2023-01-26 | — | — | US | disclosed |
| EP-3476904-B1 | SURFACE TREATMENT LIQUID AND SURFACE TREATMENT METHOD | TOKYO OHKA KOGYO CO LTD (JP) | 2023-01-18 | — | — | EP | disclosed |
| US-11198772-B2 | Surface treatment liquid and surface treatment method | TOKYO OHKA KOGYO CO., LTD. (JP) | 2021-12-14 | — | — | US | disclosed |
| US-11167540-B2 | Method for manufacturing flow path device | TOKYO OHKA KOGYO CO., LTD. (JP) | 2021-11-09 | — | — | US | disclosed |
| US-4927807-A | RENIN INHIBITING AMIDES | ABBOTT LABORATORIES (US) | 1990-05-22 | — | — | US | disclosed |
| EP-0364804-A1 | Non-peptide renin inhibitors | ABBOTT LABORATORIES (US) | 1990-04-25 | — | — | EP | disclosed |
| WO-1990003971-A1 | NON-PEPTIDE RENIN INHIBITORS | ABBOTT LABORATORIES (US) | 1990-04-19 | — | — | WO | disclosed |
| EP-0311012-A2 | Glaucoma treatment | ABBOTT LABORATORIES (US) | 1989-04-12 | — | — | EP | disclosed |
| EP-0258289-A1 | PEPTIDE ANALOGS | ABBOTT LABORATORIES (US) | 1988-03-09 | — | — | EP | disclosed |
| WO-1987004349-A1 | PEPTIDE ANALOGS | DELLARIA JOSEPH | 1987-07-30 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230381326-A1 | DRUG DELIVERY SYSTEM FOR TREATING DISEASE | HPGDS, VHL, HPSE | ANPEP 2314/4885RNPEP 1705/4885DNPEP 435/4885 |
| US-20180333345-A1 | NON-AQUEOUS COMPOSITIONS OF POLYMERS DERIVED FROM MONOMERS HAVING ACRYLOYL MOIETY AND LACTAM MOIETY AND APPLICATIONS THEREOF | C9, C5, C1S | ANPEP 723/4885RNPEP 1528/4885DNPEP 2770/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.